Ocugen, Inc. OCGN
1.02
0.02
2.00%
as of 25 Sep
- Market cap
- $339.1M
- P/E
- 0.0×
Follow OCGN
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
0.00 | 0.00 | 0.00 | 0.00 |
+8 more quarters Free account |
P/S ratio |
113.14 | 132.78 | 91.83 | 92.28 | |
P/FCF ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
P/Operating CF |
(42.48) | (27.20) | (29.03) | (38.37) | |
P/B ratio |
0.00 | 102.13 | 0.00 | 140.26 | |
Price to Tangible BV |
0.00 | 105.77 | 0.00 | 148.67 | |
EV/Sales |
91.68 | 132.18 | 94.14 | 91.75 | |
EV/EBITDA |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Operating CF |
(6.90) | (9.94) | (7.29) | (9.23) | |
EV/FCF |
(6.88) | (9.91) | (7.27) | (9.20) | |
Quick Ratio |
0.75 | 1.54 | 0.81 | 1.60 | |
Current Ratio |
0.80 | 1.86 | 1.06 | 1.85 | |
Net Debt/EBITDA |
7.05 | 0.16 | (0.64) | 0.25 | |
Debt/Assets |
1.41% | 51.30% | 66.16% | 49.31% | |
Debt/Equity |
(0.11) | 5.03 | (2.37) | 8.04 | |
Asset Turnover |
0.05 | 0.07 | 0.07 | 0.09 | |
Operating CF/Net income |
0.49 | 1.14 | 0.79 | 0.64 | |
Capex/Depreciation |
(0.01) | (0.01) | (0.04) | (0.10) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
718.41% | 734.18% | (5,528.50%) | 636.36% | |
Selling, General and Administrative Expense of Revenue |
486.69% | 529.48% | (3,177.20%) | 469.63% | |
Intangible Assets out of Total Assets |
0.00 | 0.00 | 0.00 | 0.00 | |
Share Based Compensation of Revenue |
123.19% | 221.66% | (1,037.31%) | 112.73% | |
Graham Net Nets |
(0.07) | (0.02) | (0.08) | (0.03) | |
Graham Number |
0.53 | 0.00 | 0.46 | 0.00 | |
Earnings Yield |
(16.99%) | (13.26%) | (17.04%) | (13.50%) | |
Free Cash Flow Yield |
(11.78%) | (10.05%) | (14.10%) | (10.80%) | |
Revenue per Share |
0.00 | 0.00 | 0.00 | 0.01 | |
Operating CF per Share |
(0.04) | (0.07) | (0.05) | (0.04) | |
Capex per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Free Cash Flow per Share |
(0.04) | (0.07) | (0.05) | (0.04) | |
Cash per Share |
0.30 | 0.10 | 0.06 | 0.11 | |
Shareholders Equity per Share |
(0.05) | 0.02 | (0.04) | 0.01 | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(0.05) | 0.02 | (0.04) | 0.01 | |
Free Cash Flow |
(12.22) | (21.80) | (14.00) | (13.01) | |
Working Capital |
(26.36) | 17.84 | 1.30 | 17.28 | |
Capital Expenditures |
(0.02) | (0.01) | (0.03) | (0.09) | |
Net Current Asset Value |
(34.04) | (12.55) | (31.34) | (16.42) | |
EV/EBIT |
0.00 | 0.00 | 0.00 | 0.00 | |
Capex to Sales |
0.01 | 0.00 | (0.18) | 0.05 | |
Net Profit Margin |
(1,671.84%) | (1,250.95%) | 9,174.09% | (1,144.46%) | |
Price to Operating Income |
0.00 | 0.00 | 0.00 | 0.00 | |
| Other line items | |||||
Average Payables |
4.69 | 3.23 | 5.22 | 3.03 | |
Average Assets |
88.90 | 60.68 | 62.98 | 59.77 | |
Average Common Equity |
(6.75) | 10.86 | 8.73 | 22.08 |
Columns are period end dates